Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Human reliability assessment of intelligent coal mine hoist system based on Bayesian network.

Scientific reports·2022
Same author

Application of Deep Learning on Single-cell RNA Sequencing Data Analysis: A Review.

Genomics, proteomics & bioinformatics·2022
Same author

Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data.

Frontiers in genetics·2022
Same author

Natural oscillation frequencies of a Rayleigh sphere levitated in standing acoustic waves.

The Journal of the Acoustical Society of America·2022
Same author

Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer.

Journal of medicinal chemistry·2022
Same author

Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial.

International journal of cancer·2022
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Xinyi Xia1, Xinyu Zhang2, Qi Qin1

  • 1Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, Beijing, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

血清中的新型7-microRNA (miRNA) 面板显示了对诊断阿尔茨海默病 (AD) 的高准确性. 这种微创血检与认知衰退和AD关键生物标志物相关.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 生物化学 生物化学
  • 遗传学 是一个遗传学.
  • 神经科学是一个神经科学.

背景情况:

  • 微RNAs (miRNAs) 被研究为阿尔茨海默病 (AD) 的稳定,基于血液的生物标志物.
  • miRNAs在AD病变发生过程中涉及的生物途径中发挥调节作用.
  • 这项研究的重点是开发使用血清miRNAs的诊断面板.

研究的目的:

  • 开发和验证一种基于血清的microRNA (miRNA) 面板,用于阿尔茨海默病 (AD) 诊断.
  • 在独立的队列中评估miRNA小组的诊断准确性.
  • 评估miRNA面板与认知功能和AD生物标志物的关联.

主要方法:

  • 从474名参与者 (阿尔茨海默病和健康对照) 的血清样本在发现,培训和验证队列中进行了分析.
  • 使用小RNA测序和定量PCR (qPCR) 确定了一个7-miRNA签名.
  • 机器学习模型被用来验证miRNA小组的诊断性能.

主要成果:

  • 7-miRNA小组实现了高的诊断准确性,在培训队列中,曲线下的面积 (AUC) 为0.970,在验证队列中为0.928.
  • 来自该小组的风险评分与认知障碍有显著的相关性 (MMSE评分,r = -0.72).
  • 该小组还显示了与等离子粉样蛋白病理学生物标志物的显著关联,包括Aβ42/40比率 (r = -0.25) 和p-tau217 (r = 0.36).

结论:

  • 开发的基于血清的7-miRNA小组显示出对精确的阿尔茨海默病诊断有很大的潜力.
  • 这种方法为AD检测提供了一种最少的侵入性和可访问的方法.
  • 这些发现支持循环miRNAs作为AD诊断中有价值的生物标志物的实用性.